Pfizer Meningitis B Vaccine Shows Positive Results

Pfizer said its Trumenba meningitis B vaccine showed positive results when administered with meningitis vaccines approved for other strains of the disease met its goals in a Phase 2 study for children ages 10 through 12.



from WSJ.com: US Business http://ift.tt/1BNr62h

via IFTTT